Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae-Reference-Cited by-同舟云学术

Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae

Published:2019-12-20 Issue:1 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Loose Maria¹^ORCID,Link Isabell¹,Naber Kurt G.²,Wagenlehner Florian M. E.¹

Affiliation:

1. Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany

2. Technical University of Munich, Munich, Germany

Abstract

The increasing global prevalence of carbapenem-resistant Enterobacteriaceae (CRE) combined with the decline in effective therapies is a public health care crisis. After respiratory tract infections, urinary tract infections and associated urosepsis are the second most affected by CRE pathogens.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01839-19

Reference34 articles.

1. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study

2. Antibiotics and Resistance of Uropathogens

3. European Centre for Disease Prevention and Control. 2018. Rapid risk assessment: carbapenem-resistant Enterobacteriaceae—first update. ECDC, Stockholm, Sweden.

4. New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections

5. Species-specific activity of antibacterial drug combinations

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EFFECT OF METHYLENE BLUE, EOSIN METHYLENE BLUE AGAR, AND COMBINATIONAL ANTIBIOTIC ON CARBAPENEM RESISTANCE OF ACINETOBACTER BAUMANNII VIA IN VITRO AND IN SILICO APPROACH;Applied Ecology and Environmental Research;2024

2. In vitro Synergistic Activities of Fosfomycin in Combination with Other Antimicrobial Agents Against Carbapenem-Resistant Escherichia coli Harboring blaNDM-1 on the IncN2 Plasmid and a Study of the Genomic Characteristics of These Pathogens;Infection and Drug Resistance;2022-04

3. Global Threat of Carbapenem-Resistant Gram-Negative Bacteria;Frontiers in Cellular and Infection Microbiology;2022-03-15

4. Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection: A Five-Year Retrospective Study;Infection and Drug Resistance;2022-02

5. Synergy of the Bacteriocin AS-48 and Antibiotics against Uropathogenic Enterococci;Antibiotics;2020-09-02